Pictet Asset Management (Switzerland)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $2.64M | Sell |
350,285
-13,500
| -4% | -$102K | ﹤0.01% | 871 |
|
|
2023
Q1 | $3.22M | Buy |
363,785
+18,200
| +5% | +$161K | ﹤0.01% | 854 |
|
|
2022
Q4 | $3.15M | Buy |
345,585
+8,300
| +2% | +$75.7K | ﹤0.01% | 843 |
|
|
2022
Q3 | $2.72M | Buy |
337,285
+14,460
| +4% | +$117K | ﹤0.01% | 857 |
|
|
2022
Q2 | $2.43M | Sell |
322,825
-42,625
| -12% | -$321K | ﹤0.01% | 906 |
|
|
2022
Q1 | $3.43M | Buy |
365,450
+40,500
| +12% | +$380K | ﹤0.01% | 877 |
|
|
2021
Q4 | $2.6M | Sell |
324,950
-9,100
| -3% | -$72.9K | ﹤0.01% | 957 |
|
|
2021
Q3 | $3.28M | Buy |
+334,050
| New | +$3.28M | ﹤0.01% | 917 |
|